Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Pazopanib (GW-786034): Mechanistic Depth and Predictive Biom
2026-07-06
Explore how Pazopanib (GW-786034) enables advanced cancer research through multi-targeted inhibition and predictive biomarker integration. This article offers a distinct, in-depth analysis of ATRX-deficient glioma vulnerability, assay optimization, and future directions.
-
Captopril’s Dual Impact: ACE Inhibition in Hypertension and
2026-07-06
Explore how Captopril’s precise ACE inhibition not only revolutionizes hypertension research but also opens new avenues in oncology via apoptosis induction. This article bridges mechanistic insights—such as bradykinin B2 receptor modulation of gut motility—with actionable guidance for translational researchers, distinguishing APExBIO’s Captopril as the gold standard for advanced experimental design.
-
Ceramides Promote Viral Replication via Autophagy in RGNNV I
2026-07-05
This study leverages global lipidomics to demonstrate that ceramides are crucial pro-viral mediators in red-spotted grouper nervous necrosis virus (RGNNV) infection. By elucidating the mechanistic link between ceramide metabolism and autophagy, the research suggests new avenues for antiviral strategies in aquaculture.
-
Troglitazone: Applied PPARγ Agonist Workflows in Tumor and M
2026-07-04
Troglitazone is a dual PPARγ/α agonist empowering both type 2 diabetes and anti-tumor studies through precise modulation of nuclear receptor pathways. This article delivers protocol-driven, literature-backed strategies and troubleshooting tips for maximizing reproducibility and biological insight using APExBIO’s high-purity troglitazone.
-
EdU Imaging Kits (488): Reliable S-Phase DNA Synthesis Detec
2026-07-03
EdU Imaging Kits (488) enable sensitive, DNA synthesis-specific cell proliferation assays using 5-ethynyl-2'-deoxyuridine and click chemistry. These kits outperform traditional BrdU assays by preserving cell integrity and improving workflow efficiency. Their validated performance supports advanced applications in research and diagnostics.
-
FGFR4-Variant CRC Organoids Advance Drug Sensitivity Profili
2026-07-03
This study pioneers the use of patient-derived colorectal cancer organoids with FGFR4 variants and wild-type genotypes to directly compare responses to targeted and chemotherapeutic agents. The findings highlight the non-selective efficacy of FGFR4 inhibitors and elucidate key downstream signaling pathways involved in tumor suppression.
-
TTP Modulates m6A-Dependent TGF-β1 mRNA Stability in Liver F
2026-07-02
This study uncovers a novel mechanism by which tristetraprolin (TTP) mitigates schistosomiasis-induced liver fibrosis through m6A-mediated destabilization of TGF-β1 mRNA. The findings provide a foundation for targeting epitranscriptomic regulation in hepatic fibrosis and highlight new directions for methylation-focused research.
-
Y-27632 dihydrochloride: Optimizing ROCK Inhibition in Cance
2026-07-02
Y-27632 dihydrochloride, a highly selective ROCK inhibitor, empowers researchers with reproducible modulation of cytoskeletal dynamics and tumor invasion. Learn how protocol-driven workflows and troubleshooting strategies unlock its full potential in translational cancer and stem cell biology.
-
Captopril and Bradykinin: Unraveling ACE Inhibition Beyond B
2026-07-01
Explore how Captopril, a potent ACE inhibitor, influences both hypertension and gastrointestinal peristalsis via bradykinin modulation. This article offers a deep dive into novel mechanistic insights and advanced applications for researchers.
-
Transmission Dynamics of Carbapenemase Genes in CREC in Guan
2026-07-01
This study provides an in-depth molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. Through plasmid profiling, conjugation assays, and genotyping, the research reveals high prevalence and transfer efficiency of blaNDM-1 and related genes, highlighting urgent challenges for antimicrobial stewardship and Gram-negative infection research.
-
Nilotinib (AMN-107): Unlocking BCR-ABL and Ribosomal Stress
2026-06-30
This thought-leadership article explores the dual frontier of kinase signaling and ribosomal stress in translational cancer research, positioning Nilotinib (AMN-107) as both a precision tool and strategic asset. We integrate mechanistic insights from the latest studies on ribotoxic stress and BCR-ABL pathway inhibition, offer protocol guidance, and delineate actionable opportunities for researchers driving innovation beyond established paradigms.
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Engineering Extrahepatic Imm
2026-06-30
Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) enables precise, extrahepatic immune modulation through advanced mRNA engineering and biomimetic delivery. This article delivers a deeper mechanistic analysis for translational immunotherapy applications.
-
Ribonuclease R (20 U/μL): Redefining Circular RNA Validation
2026-06-29
Explore how Ribonuclease R (20 U/μL) revolutionizes circular RNA validation and DNA damage pathway studies. This article reveals advanced assay strategies, bridges circRNA biology with inflammation mechanisms, and provides expert protocol guidance for next-generation RNA research.
-
TBK1 Inhibition Alleviates Diabetic Neuropathy via Microglia
2026-06-29
Liao et al. uncover that TANK-binding kinase 1 (TBK1) drives painful diabetic neuropathy (PDN) by promoting microglial pyroptosis. Their mechanistic work demonstrates that TBK1 inhibition—either genetically or pharmacologically—reduces neuropathic pain and supports new therapeutic strategies for PDN.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Elevating Mouse IgG
2026-06-28
The Cy3 Goat Anti-Mouse IgG (H+L) Antibody delivers high-sensitivity mouse IgG detection, transforming immunofluorescence and proteomics workflows. Its robust signal amplification and reliable performance empower biomarker discovery in complex disease models and translational research.